CD19 Targeted CAR T-cell Therapy in LBCL

Dr. Wierda on Using CD19-Targeted CAR T Cells in CLL

CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s Experience

Dr. Park on Using CD19-Targeted CAR T Cells as Treatment for ALL

Efficacy and safety of CD19-targeted CAR T-cells for relapsed/refractory ALL

CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell ALL

Bispecific CAR T-cell therapy: combining anti-CD19 and CD22 CAR T-cells

Current research on CD19 targeted CAR T-cells in relapsed B-cell ALL

Evaluating dual-targeting CD19/22 CAR-T cells in patients with R/R ALL

CD19 Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus

Second CD19-targeted CAR T-cell infusion for R/R B-cell malignancies

Long-term trial supports CD19-targeted CAR T cells for relapsed/refractory CLL

A Look at How CAR-T Cell Therapy Works

CD19 CAR T-cells for adults

Findings for CD19-Targeted CAR T Cells in Combination With Ibrutinib in CLL

Humanized versus murinized CD19/CD22 CAR-T cell therapy for R/R B-cell lymphoma

CAR T Cell Therapy Explained (Animation) | City of Hope

CD19 and CD20 CAR T-cell therapy for non-Hodgkin lymphoma

A Look at How CAR-T Cell Therapy Works

CAR T-cell Therapy for Pediatric Cancer | Satiro de Oliveira, MD | UCLAMDChat